The findings, which were presented over the weekend at ENDO 2026, the Endocrine Society's annual meeting, were based on an analysis of health records from more than 42,000 adults who were already taking at least two types of blood pressure medications when they began treatment with GLP-1 drugs such as semaglutide, tirzepatide or liraglutide
The following sections will detail these safety measures and how labs guide your care
Jonathan Yellen, FelCor Lodging Trust OUTSTANDING GENERAL COUNSEL OR CHIEF LEGAL OFFICER-MIDSIZE LEGAL DEPARTMENT Kathryn Kotel Carlson Restaurants Worldwide When the recession turned the tables on the restaurant industry, Kathryn Kotel changed the business recipe instead
How can drug addiction help us understand obesity
People will need to be obese or overweight and have at least one weight-related health condition to use GLP-1 medications
When we asked support for a full price sheet, the reply said pricing may change and declined to share it